Delivery Order SPE2DB20D1100-SPE2DB24FA5D7
Award Date
3/1/24
Potential Completion Date
3/4/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,239.50, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. This contract does not have a set-aside designation, indicating it was competitively awarded....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a ceiling value of $2,714.70 and a period of performance through February 18, 2025. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that serves as a primary vehicle for AmerisourceBergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $4,862.12, is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of October 8, 2024. The contract was awarded on October 7, 2024 and does not have a set-aside designation. AmerisourceBergen, a major...
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,097.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has an ultimate completion date of May 24, 2024 and was awarded on May 23, 2024. It is not set aside for any special designation. Amerisourcebergen, a subsidiary...
The federal contract award with ID SPE2DB20D1109|SPE2DB24FN35H was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,295.20 firm fixed-price delivery order is for the drug Hemabate 250 mcg/ml, which is likely used for medical treatment purposes. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
This is a $24,673.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hemlibra 105 mg/0.7 ml vials, a specialty medication. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,336.54 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,636.40 firm-fixed-price contract was awarded on February 5, 2025 with a completion date of February 6, 2025. The contract, which does not have a set-aside designation, provides for the delivery of various pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,028.56 firm-fixed-price contract will run through February 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,512.55 firm fixed-price contract covers the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of March 18,...